Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial of Conventional vs IMRT Whole Brain Radiotherapy for Brain Metastases

NCT01890278 is registered in ClinicalTrials.gov with Good Samaritan Hospital Medical Center, New York as lead sponsor.

NCT NCT01890278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01890278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial of Conventional vs IMRT Whole Brain Radiotherapy for Brain Metastases
Lead sponsor
Good Samaritan Hospital Medical Center, New York
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2013
Completion date
March 31, 2017
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic brain cancer